{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:28:54Z","timestamp":1794216534167,"version":"4.8.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jneuroim.2026.579078","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:28:09Z","timestamp":1787786889000},"page":"579078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Spatial and temporal changes in [3H]JNJ-64413739 binding to purinergic P2X7 receptor (P2X7R) after status epilepticus induced by intracerebral kainic acid in the rat"],"prefix":"10.1016","volume":"421","author":[{"given":"Kristin H.","family":"Magnusdottir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu A.","family":"Pazarlar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansu B.","family":"Egilmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens D.","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2026.579078_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.00124","article-title":"The P2X7 receptor: central hub of brain diseases","volume":"13","author":"Andrejew","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"Suppl. 3","key":"10.1016\/j.jneuroim.2026.579078_bb0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/epi.13783","article-title":"Neuroinflammatory targets and treatments for epilepsy validated in experimental models","volume":"58","author":"Aronica","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneuroim.2026.579078_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2009.03.003","article-title":"The descriptive epidemiology of epilepsy-a review","volume":"85","author":"Banerjee","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0020","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/pr.113.008003","article-title":"The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease","volume":"66","author":"Bartlett","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2021.102105","article-title":"ATP and adenosine-two players in the control of seizures and epilepsy development","volume":"204","author":"Beamer","year":"2021","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0030","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00259-021-05449-2","article-title":"What value can TSPO PET bring for epilepsy treatment?","volume":"49","author":"Bouilleret","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jneuroim.2026.579078_bb0035","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2967\/jnumed.116.172494","article-title":"Serial quantitative TSPO-targeted PET reveals peak microglial activation up to 2 weeks after an epileptogenic brain insult","volume":"57","author":"Brackhan","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0040","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.0013-9580.2004.17004.x","article-title":"High-frequency oscillations after status epilepticus: epileptogenesis and seizure genesis","volume":"45","author":"Bragin","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneuroim.2026.579078_bb0045","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1016\/j.bmcl.2015.06.001","article-title":"Docking of competitive inhibitors to the P2X7 receptor family reveals key differences responsible for changes in response between rat and human","volume":"25","author":"Caseley","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0050","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1742-2094-6-38","article-title":"Cellular injury and neuroinflammation in children with chronic intractable epilepsy","volume":"6","author":"Choi","year":"2009","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2026.579078_bb0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0079-6123(08)63569-4","article-title":"The P2Z\/P2X7 receptor of microglial cells: a novel immunomodulatory receptor","volume":"120","author":"Di Virgilio","year":"1999","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.eplepsyres.2008.10.008","article-title":"Alteration of purinergic P2X4 and P2X7 receptor expression in rats with temporal-lobe epilepsy induced by pilocarpine","volume":"83","author":"Dona","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107735","article-title":"Biomarkers for epileptogenesis and its treatment","volume":"167","author":"Engel","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jneuroim.2026.579078_bb0075","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1096\/fj.11-196089","article-title":"Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice","volume":"26","author":"Engel","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0080","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/(SICI)1097-4547(20000415)60:2<266::AID-JNR16>3.0.CO;2-P","article-title":"Increased expression of mRNA encoding interleukin-1beta and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration","volume":"60","author":"Eriksson","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0085","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.mehy.2011.02.039","article-title":"A new hypothesis of drug refractory epilepsy: neural network hypothesis","volume":"76","author":"Fang","year":"2011","journal-title":"Med. Hypotheses"},{"issue":"59","key":"10.1016\/j.jneuroim.2026.579078_bb0090","doi-asserted-by":"crossref","DOI":"10.3791\/3528","article-title":"Rodent stereotaxic surgery and animal welfare outcome improvements for behavioral neuroscience","author":"Fornari","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0095","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1021\/acs.molpharmaceut.4c01458","article-title":"Evaluation of [(18)F]F-PTTP as a positron emission tomography radioligand for imaging P2X7 receptors in epileptic rats","volume":"22","author":"Fu","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042380","article-title":"Beyond seizure control: treating comorbidities in epilepsy via targeting of the P2X7 receptor","volume":"23","author":"Gil","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0105","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1021\/acs.jmedchem.0c02249","article-title":"Synthesis and characterization of the novel rodent-active and CNS-penetrant P2X7 receptor antagonist Lu AF27139","volume":"64","author":"Hopper","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000026433","article-title":"Cytokine effects on glutamate uptake by human astrocytes","volume":"7","author":"Hu","year":"2000","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jneuroim.2026.579078_bb0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12031-017-0968-z","article-title":"Inhibition of P2X7 receptor ameliorates nuclear factor-kappa B mediated neuroinflammation induced by status epilepticus in rat Hippocampus","volume":"63","author":"Huang","year":"2017","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0120","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/epi.12257","article-title":"Increased neocortical expression of the P2X7 receptor after status epilepticus and anticonvulsant effect of P2X7 receptor antagonist A-438079","volume":"54","author":"Jimenez-Pacheco","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneuroim.2026.579078_bb0125","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1523\/JNEUROSCI.4009-15.2016","article-title":"Transient P2X7 receptor antagonism produces lasting reductions in spontaneous seizures and gliosis in experimental temporal lobe epilepsy","volume":"36","author":"Jimenez-Pacheco","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0130","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36217","article-title":"Re-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody","volume":"7","author":"Kaczmarek-Hajek","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.jneuroim.2026.579078_bb0135","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2967\/jnumed.118.212696","article-title":"Preclinical evaluation and nonhuman primate receptor occupancy study of (18)F-JNJ-64413739, a PET radioligand for P2X7 receptors","volume":"60","author":"Kolb","year":"2019","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0140","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2967\/jnumed.118.216747","article-title":"(18)F-JNJ-64413739, a novel PET ligand for the P2X7 ion channel: radiation dosimetry, kinetic modeling, test-retest variability, and occupancy of the P2X7 antagonist JNJ-54175446","volume":"60","author":"Koole","year":"2019","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0145","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S1474-4422(20)30346-X","article-title":"PET imaging of neuroinflammation in neurological disorders","volume":"19","author":"Kreisl","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0150","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0169-328X(02)00654-X","article-title":"Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures","volume":"110","author":"Lehtimaki","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0160","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.neubiorev.2013.10.011","article-title":"The kainic acid model of temporal lobe epilepsy","volume":"37","author":"Levesque","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113821","article-title":"Unraveling the priming phase of NLRP3 inflammasome activation: molecular insights and clinical relevance","volume":"146","author":"Liao","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0170","article-title":"NF-kappaB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0175","doi-asserted-by":"crossref","first-page":"16172","DOI":"10.1038\/s41598-021-95715-y","article-title":"Minimally invasive quantification of cerebral P2X7R occupancy using dynamic [(18)F]JNJ-64413739 PET and MRA-driven image derived input function","volume":"11","author":"Mertens","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0180","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1021\/acschemneuro.2c00561","article-title":"Characterization of the novel P2X7 receptor radioligand [(3)H]JNJ-64413739 in human brain tissue","volume":"14","author":"Mikkelsen","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0185","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/0006-291X(90)91221-D","article-title":"Convulsants induce interleukin-1 beta messenger RNA in rat brain","volume":"171","author":"Minami","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0190","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0006-291X(05)80225-6","article-title":"Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain","volume":"176","author":"Minami","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0195","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1523\/JNEUROSCI.5512-08.2009","article-title":"The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore","volume":"29","author":"Monif","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0200","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/s12264-020-00573-9","article-title":"Characterization of the expression of the ATP-gated P2X7 receptor following status epilepticus and during epilepsy using a P2X7-EGFP reporter mouse","volume":"36","author":"Morgan","year":"2020","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0205","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/epi.17484","article-title":"Increased uptake of the P2X7 receptor radiotracer (18) F-JNJ-64413739 in the brain and peripheral organs according to the severity of status epilepticus in male mice","volume":"64","author":"Morgan","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneuroim.2026.579078_bib311","series-title":"Coordinates","article-title":"The Rat Brain in Stereotaxic","author":"Paxinos","year":"2006"},{"key":"10.1016\/j.jneuroim.2026.579078_bb0210","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022822","article-title":"Epileptogenesis","volume":"5","author":"Pitkanen","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0215","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. Part II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0220","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1600-0404.2008.01108.x","article-title":"Seizures in the intrahippocampal kainic acid epilepsy model: characterization using long-term video-EEG monitoring in the rat","volume":"119","author":"Raedt","year":"2009","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0225","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nbd.2007.08.012","article-title":"Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy","volume":"29","author":"Ravizza","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0230","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neulet.2011.02.040","article-title":"Inflammation and prevention of epileptogenesis","volume":"497","author":"Ravizza","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0235","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0337-20.2021","article-title":"The kainic acid models of temporal lobe epilepsy","volume":"8","author":"Rusina","year":"2021","journal-title":"eNeuro"},{"key":"10.1016\/j.jneuroim.2026.579078_bb0240","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.neuron.2021.01.027","article-title":"White matter aging drives microglial diversity","volume":"109","author":"Safaiyan","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2026.579078_bb0245","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135391","article-title":"Reactive astrocyte-driven epileptogenesis is induced by microglia initially activated following status epilepticus","volume":"6","author":"Sano","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jneuroim.2026.579078_bb0250","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ncl.2016.06.015","article-title":"The epidemiology of global epilepsy","volume":"34","author":"Singh","year":"2016","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0255","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/bph.16033","article-title":"The P2X7 receptor contributes to seizures and inflammation-driven long-lasting brain hyperexcitability following hypoxia in neonatal mice","volume":"180","author":"Smith","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0260","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2014.08.002","article-title":"P2X7 receptor: an emerging target in central nervous system diseases","volume":"35","author":"Sperlagh","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00301","article-title":"Drug-resistant epilepsy: multiple hypotheses, few answers","volume":"8","author":"Tang","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0270","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2026.579078_bb0275","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/nan.12150","article-title":"Review: hippocampal sclerosis in epilepsy: a neuropathology review","volume":"40","author":"Thom","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0280","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fnana.2018.00090","article-title":"The absolute number of oligodendrocytes in the adult mouse brain","volume":"12","author":"Valerio-Gomes","year":"2018","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0285","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1523\/JNEUROSCI.19-12-05054.1999","article-title":"Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures","volume":"19","author":"Vezzani","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0290","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1523\/JNEUROSCI.23-25-08692.2003","article-title":"Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases","volume":"23","author":"Viviani","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0295","doi-asserted-by":"crossref","first-page":"1403232","DOI":"10.3389\/fphar.2024.1403232","article-title":"Phytotherapeutic options for the treatment of epilepsy: pharmacology, targets, and mechanism of action","volume":"15","author":"Waris","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0300","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12974-020-01907-0","article-title":"Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration","volume":"17","author":"Woollacott","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2026.579078_bb0305","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3892\/ijmm.2014.1755","article-title":"Lipopolysaccharide\/adenosine triphosphate induces IL-1beta and IL-18 secretion through the NLRP3 inflammasome in RAW264.7 murine macrophage cells","volume":"34","author":"Xie","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jneuroim.2026.579078_bb0310","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome activation and regulation: toward a better understanding of complex mechanisms","volume":"6","author":"Zheng","year":"2020","journal-title":"Cell Discov."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826002274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826002274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:18:41Z","timestamp":1794215921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826002274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":63,"alternative-id":["S0165572826002274"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579078","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spatial and temporal changes in [3H]JNJ-64413739 binding to purinergic P2X7 receptor (P2X7R) after status epilepticus induced by intracerebral kainic acid in the rat","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"579078"}}